Arq Bras Cardiol
October 2024
Background: Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular risk in patients with chronic kidney disease (CKD).
Objective: This study aimed to compare and correlate OPG values with flow-mediated dilation (FMD) and pulse wave velocity (PWV) measurements in patients in stage 3 CKD and those without renal dysfunction.
Methods: This case-control study was conducted in a specialized hypertension center in 2022.